EcoDrugPlus

Glucokinase

Ensembl ID : ENSMSIG00000019231
Gene Symbol: GCK
1 Cross references
226 Possible Orthologues:

Glucosidase, Alpha, Acid

Ensembl ID : ENSMSIG00000016625
Gene Symbol: GAA
1 Cross references
249 Possible Orthologues:

Glucosidase, Beta, Acid

Ensembl ID : ENSMSIG00000025996
Gene Symbol: GBA
1 Cross references
269 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda3a

Ensembl ID : ENSMSIG00000026757
Gene Symbol: GRIN3A
1 Cross references
260 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa2 (Alpha 2)

Ensembl ID : ENSMSIG00000005529
Gene Symbol: GRIA2
1 Cross references
336 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa3 (Alpha 3)

Ensembl ID : ENSMSIG00000024573
Gene Symbol: GRIA3
1 Cross references
333 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa4 (Alpha 4)

Ensembl ID : ENSMSIG00000004835
Gene Symbol: GRIA4
1 Cross references
339 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda1 (Zeta 1)

Ensembl ID : ENSMSIG00000023294
Gene Symbol: GRIN1
1 Cross references
293 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda2a (Epsilon 1)

Ensembl ID : ENSMSIG00000002310
Gene Symbol: GRIN2A
1 Cross references
242 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda2b (Epsilon 2)

Ensembl ID : ENSMSIG00000006421
Gene Symbol: GRIN2B
1 Cross references
345 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda2c (Epsilon 3)

Ensembl ID : ENSMSIG00000028476
Gene Symbol: GRIN2C
1 Cross references
259 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda3b

Ensembl ID : ENSMSIG00000002569
Gene Symbol: GRIN3B
1 Cross references
301 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).